Baxter International (NYSE:BAX) Price Target Raised to $54.00

Baxter International (NYSE:BAX – Free Report) had its target price lifted by Barclays from $52.00 to $54.00 in a research report sent to investors on Monday morning, Benzinga reports. Barclays currently has an overweight rating on the medical instruments supplier’s stock. Several other research firms also recently weighed in on BAX. StockNews.com upgraded Baxter International […]

Related Keywords

,Morgan Stanley ,Deutsche Bank Aktiengesellschaft ,Ancora Advisors ,Baxter International Trading ,Baxter International Company Profile ,Eudaimonia Partners ,News Ratings For Baxter International Daily ,Hedge Funds Weigh In On Baxter International ,Gabelli Funds ,Barclays ,Jpmorgan Chase Co ,Baxter International ,Kb Financial Partners ,Baxter International Inc ,Analyst Recommendations For Baxter International ,Baxter International Dividend Announcement ,Free Report ,Bank Aktiengesellschaft ,Get Free Report ,International Inc ,Baxter International Daily ,Nyse Bax ,Bax ,Medical ,07181310 ,Boost Price Target ,Barclays Plc ,